Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitro
References (29)
- et al.
Life Sci.
(1996) - et al.
Cancer Lett.
(1994) - et al.
Cancer Lett.
(1995) - et al.
Life Sci.
(1996) - et al.
J. Biol. Chem.
(1995) - et al.
- et al.
- et al.
J. Neural Transm. (suppl)
(1986) - et al.
Cancer Res.
(1998) - et al.
J. Pineal Res.
(1991)
Crit. Rev. Eucar. Gene Exp.
(1992)
Cell
(1993)
J. Pineal Res.
(1995)
J. Pineal Res.
(1993)
Cited by (190)
Nanocomposite zinc oxide@ γ-linolenic acid-canagliflozin-fucoxanthin and/or γ-radiation perturbs key metabolic effectors and suppresses the proliferation of breast cancer cells in vitro
2023, Journal of Drug Delivery Science and TechnologyTherapeutic potential of melatonin in glioblastoma: Current knowledge and future prospects
2023, Biomarkers in Cancer Detection and Monitoring of Therapeutics: Diagnostic and Therapeutic Applications: Volume 2Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy
2021, Redox BiologyCitation Excerpt :Melatonin's effect on invasion and metastasis is partly mediated by a melatonin-induced increased expression of the cell surface adhesion proteins E-cadherin and beta(1)-integrin [34]. Physiological concentrations of melatonin have been shown to decrease the growth rate of breast cancer cells by increased expression of p21/WAF1 along with p53 [34]. Increased expression of p53 promotes genetic stability and makes cells less prone to tumor formation [35].
Mechanisms of melatonin in anti-aging and its regulation effects in radiation-induced premature senescence
2021, Radiation Medicine and Protection
Copyright © 1999 Published by Elsevier Inc.